Taipei Exchange - Delayed Quote TWD

Synmosa Biopharma Corporation (4114.TWO)

Compare
33.00 -0.50 (-1.49%)
At close: December 13 at 1:30:37 PM GMT+8

Key Executives

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Mr. Chih-Hui Lin Chairman, GM, Managerial Officer & President 4.71M -- 1983
Mr. Hong-Qin Bai Senior VP & Finance Officer 3.5M -- --
Ms. Jia-Xin Zhang Senior Vice President 3.02M -- --
Mr. Sheng-Ren Yang Senior Vice President 3.14M -- --
Liyu Huang Chief Financial Officer -- -- --
Jinghua Cao Accounting Supervisor -- -- --
Mr. Zen Young Vice President of Sales - HP, Marketing & Medical -- -- --

Synmosa Biopharma Corporation

No. 396, Neihu Road
11th Floor Section 1 Neihu District
Taipei, 114
Taiwan
886 2 8797 7100 https://www.synmosa.com.tw
Sector: 
Healthcare

Description

Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan. It offers its products in various therapeutic areas, including cardiovascular, respiratory, urology, sex hormone, and oncology. The company provides its products in various forms, such as effervescent tablets, granules, nasal sprays, metered dosed inhalers, hormones, and other forms. It also offers contract manufacturing services. In addition, it exports its products to South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua. Synmosa Biopharma Corporation was incorporated in 1980 and is based in Taipei, Taiwan.

Corporate Governance

Synmosa Biopharma Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

August 9, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers